Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, Manchandani U. Failure of the PD-1 blocking agent pembrolizumab to benefit a patient with renal squamous cell cancer. EJCRIM 2024;11 doi:10.12890/2024_004619.